CWC
KRTX

Carolinas Wealth Consulting’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Carolinas Wealth Consulting’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19
Closed -$6.01K – 1178
2023
Q4 		$6.01K Buy
+19
New +$3.69K ﹤0.01% 599
2020
Q4 		– Sell
-13
Closed -$1K – 1051
2020
Q3 		$1K Buy
+13
New +$1.11K ﹤0.01% 906

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Carolinas Wealth Consulting's KRTX Position: Q1 2024 in Review

Carolinas Wealth Consulting sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 19 shares — an estimated $6.01K sold.

Carolinas Wealth Consulting first reported a position in KRTX in Q3 2020 and held it in 2 quarters. The position peaked at $6.01K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Carolinas Wealth Consulting reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 19 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $6.01K.
  • Carolinas Wealth Consulting first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Carolinas Wealth Consulting's Karuna Therapeutics, Inc. Common Stock position peaked at $6.01K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Carolinas Wealth Consulting's 13F filing for Q1 2024, filed 15 May 2024.